Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the class of heteroaryl acetic acid derivatives. It is a non-selective cyclooxygenase (COX) inhibitor, being marketed as an analgesic to manage postoperative pain as well as an ophthalmic solution to treat ocular pain and inflammation. Ketorolac potently inhibits COX-1 and COX-2 (IC50s = 20 nM) in vivo. In a mouse model of acute pain, ketorolac 30 mg/kg suppressed both pain and peripheral PGE2 levels. As typical of many NSAIDs, ketorolac is a racemic mixture. (S)-Ketorolac exhibits potent COX1 and COX2 (IC50s = 0.1 and 2.7 uM) inhibition, whereas (R)-ketorolac is >100-fold less active on both COX subtypes.
产品描述
An NSAID, non-selective COX inhibitor, being marketed as an analgesic to manage postoperative pain as well as an ophthalmic solution to treat ocular pain and inflammation; inhibits COX-1 and COX-2 (IC50s = 20 nM) in vivo